PHAT - Phathom Pharmaceuticals, Inc.

QQQ $ 426.74 $ 1.50 (0.35 %)

DIA $ 381.76 $ 0.24 (0.06 %)

SPY $ 504.52 $ 0.12 (0.02 %)

TLT $ 88.88 $ 0.65 (0.74 %)

GLD $ 213.08 $ 0.62 (0.29 %)

Previous Close

$ 9.26

Open

$ 9.50

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 9.46 - $ 9.83

52 Week Range

$ 6.07 - $ 17.02

Volume

512,297

Average Volume

Market Cap

474.94M

Beta (5Y Monthly)

$ 1.04

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-07-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-10-2023	06-30-2023	10-Q
4	05-10-2023	03-31-2023	10-Q
5	02-28-2023	12-31-2022	10-K
6	11-08-2022	09-30-2022	10-Q
7	08-02-2022	06-30-2022	10-Q
8	05-10-2022	03-31-2022	10-Q
9	03-01-2022	12-31-2021	10-K
10	11-08-2021	09-30-2021	10-Q
11	08-10-2021	06-30-2021	10-Q
12	05-11-2021	03-31-2021	10-Q
13	03-30-2021	12-31-2020	10-K
14	11-10-2020	09-30-2020	10-Q
15	08-06-2020	06-30-2020	10-Q
16	05-12-2020	03-31-2020	10-Q
17	03-19-2020	12-31-2019	10-K
18	11-25-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Reiterates Buy on Phathom Pharmace...
04/26/2024 15:16:46

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/19/2024 18:42:01

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/12/2024 14:09:27

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/11/2024 10:27:59

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/05/2024 13:43:30

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/01/2024 11:01:32

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
03/22/2024 18:14:15

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Maintains Buy on Phathom Pharmaceu...
03/15/2024 14:34:25

Needham analyst Joseph Stringer maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
03/08/2024 19:22:19

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

HC Wainwright & Co. Reiterates Buy on Phat...
03/08/2024 14:44:33

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $...

Needham Reiterates Buy on Phathom Pharmace...
03/07/2024 17:21:22

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Phathom Pharmaceuticals, As Of December 31...
03/07/2024 13:06:07

Phathom Pharmaceuticals Q4 GAAP EPS $(1.39...
03/07/2024 13:03:37

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(1.39) per share which missed the analyst consensus estimat...

Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

Preview: Phathom Pharmaceuticals's Earnings
03/06/2024 16:02:01

Needham Reiterates Buy on Phathom Pharmace...
02/23/2024 15:42:07

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Walmart Posts Upbeat Earnings, Joins Armst...
02/20/2024 15:26:52

U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
02/19/2024 17:30:50

Needham Reiterates Buy on Phathom Pharmace...
02/16/2024 18:10:11

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
02/16/2024 17:31:13